Company comparison
AstraZeneca vs AbbVie
In short
AstraZeneca plc and AbbVie Inc are both in Pharmaceuticals. ET&A currently rates AstraZeneca plc Buy and AbbVie Inc Hold. Against ET&A's Fair Value, AstraZeneca plc's share price currently looks better value — it sits further below what we think it is worth. Their investment styles differ (Quality/Growth and Quality/Growth/Income), so they may suit different goals.
Fair Value is what ET&A estimates each company is worth today; the 12M Price Target is what we think it should be worth in about twelve months; Preferred Entry is the price range where the expected return becomes attractive enough for the risk. Expected returns are measured from the price at each valuation date. This tool shows the differences and trade-offs — it does not pick a winner. See membership
Investor View
More detail, one section at a time
Open a section to compare the reasoning and the detail.
Our view on eachOur reasoning, what could drive each higher and what could go wrong.Members
The complete ET&A view
See our full reasoning, what could drive the shares higher or go wrong, our Fair Value and Preferred Entry, and how our view has changed.
- Our View in full
- What could drive it higher / go wrong
- Fair Value & Preferred Entry
- How our view has changed
Price against valueWhere each price sits between its Preferred Entry and Fair Value.Members
Fair Value & Preferred Entry
See what ET&A thinks each company is worth, the price range where we'd be happy to buy, and whether today's price looks cheap or expensive.
Business Health, area by areaEach area's rating on ET&A's scales, side by side.
The figures behind each rating are on each company’s page.
Who each suitsInvestment style and the goals each fits.
Research ViewOpen the full researchThe full researchValuation multiples and the reported financial figures, side by side.OpenClose
For detailed analysis. Each section opens on its own.
Valuation multiplesP/E, EV/EBITDA, Price/Sales and other multiples.Members
Financial figuresSize, returns and financial strength, as reported.
Values are shown in each company’s listing currency. “—” means the figure isn’t available.